Susquehanna International Group, LLP Axsome Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 320,200 shares of AXSM stock, worth $29.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

320,200

Previous 25,616 1150.0%

Holding current value

$29.8 Million

Previous $2.06 Million 1295.2%

% of portfolio

0.01%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$65.72 - $80.5 $900,692 - $1.1 Million	-13,705 Reduced 34.85%	25,616 $2.06 Million
Q1 2024 May 07, 2024	BUY	$69.39 - $97.64 $1.84 Million - $2.59 Million	26,558 Added 208.09%	39,321 $3.14 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $542,791 - $790,365	9,453 Added 285.59%	12,763 $1.02 Million
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $519,375 - $616,575	-7,500 Reduced 69.38%	3,310 $231,000
Q2 2023 Aug 11, 2023	SELL	$58.41 - $90.35 $1.31 Million - $2.02 Million	-22,368 Reduced 67.42%	10,810 $776,000
Q1 2023 May 16, 2023	BUY	$58.39 - $75.0 $1.78 Million - $2.29 Million	30,532 Added 1153.89%	33,178 $2.05 Million
Q4 2022 Feb 14, 2023	SELL	$39.94 - $79.72 $3.39 Million - $6.77 Million	-84,926 Reduced 96.98%	2,646 $204,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $1.36 Million - $2.64 Million	37,768 Added 75.83%	87,572 $3.91 Million
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $1.44 Million - $3.1 Million	-66,340 Reduced 57.12%	49,804 $1.91 Million
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $1.59 Million - $2.24 Million	-51,648 Reduced 30.78%	116,144 $4.39 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $2.16 Million - $7.42 Million	108,675 Added 183.83%	167,792 $5.53 Million
Q2 2021 Aug 11, 2021	SELL	$50.63 - $73.5 $802,485 - $1.16 Million	-15,850 Reduced 21.14%	59,117 $3.99 Million
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $778,323 - $1.13 Million	-13,921 Reduced 15.66%	74,967 $4.25 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $1.9 Million - $2.48 Million	-28,678 Reduced 24.39%	88,888 $7.24 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $1.18 Million - $1.48 Million	-17,194 Reduced 12.76%	117,566 $8.38 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $1.77 Million - $3.5 Million	-35,462 Reduced 20.83%	134,760 $11.1 Million
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $13.7 Million - $33.7 Million	-333,132 Reduced 66.18%	170,222 $10 Million
Q4 2019 Feb 14, 2020	BUY	$16.71 - $106.24 $4.26 Million - $27.1 Million	255,210 Added 102.85%	503,354 $52 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $4.13 Million - $5.95 Million	204,184 Added 464.48%	248,144 $5.02 Million
Q2 2019 Aug 16, 2019	BUY	$13.46 - $25.75 $161,546 - $309,051	12,002 Added 37.56%	43,960 $1.13 Million
Q2 2019 Aug 14, 2019	SELL	$13.46 - $25.75 $745,522 - $1.43 Million	-55,388 Reduced 63.41%	31,958 $823,000
Q1 2019 May 15, 2019	BUY	$2.63 - $16.34 $194,783 - $1.21 Million	74,062 Added 557.53%	87,346 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$2.0 - $4.15 $8,068 - $16,741	-4,034 Reduced 23.29%	13,284 $37,000
Q1 2018 May 15, 2018	SELL	$2.35 - $5.6 $120,970 - $288,271	-51,477 Reduced 74.83%	17,318 $42,000
Q4 2017 Feb 14, 2018	BUY	$4.45 - $6.2 $306,137 - $426,529	68,795	68,795 $385,000

Others Institutions Holding AXSM

# of Institutions

326

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.99B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Axsome Therapeutics, Inc. Transaction History